The transversal (or cross-regional) programs harness the expertise of St. Jude Global teams to improve standards of care and train practitioners worldwide.
The Global Critical Care Program aims to strengthen hospital care for critically ill children through innovative interventions, education, research and multidisciplinary collaboration.
The Global Culture and Communication Program strives to support the cure of childhood cancer with culturally appropriate approaches to research, education and community engagement.
The Global Disease Burden and Simulation Program provides key data on pediatric cancer and other catastrophic diseases for clinicians, health administrators and health policy stakeholders.
The Global Health Systems Unit supports the integration of childhood cancer care into global, national and regional priorities to improve health outcomes for children with cancer.
The Global Infectious Diseases Unit works to improve the survival rates for children with infectious diseases, especially those with depressed immunity.
The Global Metrics and Performance Unit equips care teams and institutions with tools to measure inequities, evaluate causes, respond to identified gaps, innovate and more.
The Global Neuro-Oncology Program strives to improve the diagnosis and treatment of, and research on, childhood brain and spinal cord cancers.
The Global Nursing Program promotes the implementation of pediatric hematology-oncology nursing standards at St. Jude partner sites.
The Global Palliative Care Program attends to the suffering of children with cancer and their families, regardless of diagnosis, prognosis or location.
The Global Pathology and Laboratory Medicine Program works with partner institutions to enhance clinical diagnostic laboratories and anatomic pathology services in low- and middle-income countries.
The Global Hematology Program seeks to advance knowledge of non-malignant catastrophic blood disorders through research, technology and organizational skills.
The Global Pharmacy Program empowers pharmacy professionals to provide quality pharmaceutical care for children with cancer and other catastrophic diseases.
The Global Retinoblastoma Program is dedicated to improving survival and vision outcomes for children with retinoblastoma worldwide.